DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings354 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

984,500$470.2M2.7%$64.83+544.06%
30 qtrssince 2019-Q1
Decreased
0

Definium Therapeutics, Inc.

6.8M$322M1.9%$17.60+132.86%
3 qtrssince 2025-Q4
Increased
56

PRAXIS PRECISION MEDICINES I

959,048$321.1M1.9%$166.75+106.74%
10 qtrssince 2024-Q1
Increased
49

XENON PHARMACEUTICALS INC

4.4M$266.7M1.5%$28.88+107.76%
26 qtrssince 2020-Q1
Decreased
0
SIMOSIMO
ADR

SILICON MOTION TECHNOL-ADR

786,074$262M1.5%$179.81+36.71%
5 qtrssince 2025-Q2
Increased
68

Spyre Therapeutics, Inc

2.8M$248.5M1.4%$23.60+282.93%
12 qtrssince 2023-Q3
Increased
48

CRINETICS PHARMACEUTICALS IN

6.5M$241.9M1.4%$26.84+216.12%
25 qtrssince 2020-Q2
Increased
49

APOGEE THERAPEUTICS INC

1.7M$231M1.3%$41.31+226.75%
12 qtrssince 2023-Q3
Decreased
0

Guardant Health, Inc.

1.5M$230.1M1.3%$45.50+254.97%
6 qtrssince 2025-Q1
Increased
48

PLANET LABS PBC

6.7M$222.7M1.3%$9.96+100.69%
5 qtrssince 2025-Q2
Decreased
0

CREDICORP LTD

557,228$217.1M1.3%$203.65+80.90%
10 qtrssince 2024-Q1
Increased
59

EDGEWISE THERAPEUTICS INC

4.7M$192.1M1.1%$22.22+92.43%
11 qtrssince 2023-Q4
Increased
51

Vicor Corporation

496,507$188.6M1.1%$311.93-39.81%
2 qtrssince 2026-Q1
Increased
78

ULTRA CLEAN HLDGS INC

1.3M$186.7M1.1%$63.78+8.93%
4 qtrssince 2025-Q3
Increased
58

CURTISS-WRIGHT CORP

229,123$173.6M1.0%$246.23+142.20%
18 qtrssince 2022-Q1
Increased
49

Xometry, Inc. Class A

1.8M$170.7M1.0%$57.64+63.27%
7 qtrssince 2024-Q4
Increased
50

TeraWulf Inc.

6.2M$152.2M0.9%$9.30+65.04%
5 qtrssince 2025-Q2
Increased
43

Septerna, Inc.

4.4M$148.5M0.9%$17.24+125.73%
7 qtrssince 2024-Q4
Increased
43

NEXTRACKER INC-CL A

1.2M$143.8M0.8%$77.66+10.02%
6 qtrssince 2025-Q1
Increased
49

CECO Environmental Corp.

1.6M$141.6M0.8%$65.87+5.78%
11 qtrssince 2023-Q4
Increased
69
$17.3B
AUM
354
Positions
Q2 2026
Filing
2.0/5
HI score
Quarterly 13F Value Change
-14%Q1'25$10.4B+20%Q2'25$12.5B+12%Q3'25$14B+5%Q4'25$14.7B-8%Q1'26$13.6B+27%Q2'26$17.3B
Activity profile
$ moved · Q2'26
New25%Increased38%Decreased19%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.2 years
<1Q10%1-4Q19%1-2Y15%2Y+56%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $17.3B across 354 positions as of Q2 2026. Top holdings: TSM (2.7%), DFTX (1.9%), PRAX (1.9%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.

Q2 2026 Summary

Active quarter - 84 new positions, 85 exits, 140 increased. Top move: VICR (INCREASED, conviction 78). Portfolio: $17.3B across 354 positions.

Top holdings by portfolio weight

Total AUM$17B
TSM2.72%
DFTX1.87%
PRAX1.86%
XENE1.55%
SIMO1.52%
SYRE1.44%
CRNX1.40%
APGE1.34%
GH1.33%
PL1.29%
Other1.26%

Portfolio allocation by GICS sector

Sectors11
Healthcare27.86%
Technology24.35%
Industrials19.34%
Financial Services9.17%
Consumer Cyclical7.20%
Energy3.98%
Basic Materials3.27%
Consumer Defensive2.31%
Communication Services0.88%
Utilities0.71%
Other0.92%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L61
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used